Jonathan B. Siegel

Jonathan B. Siegel (board member) discloses dealings in Jaguar Health, Inc. to SEC (Form 4). Over a trading history stretching from 16 July 2018 to 11 December 2025, the count stands at 10 filings.

Purchases make up the whole of the open-market record (6 purchases, €52k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 2 option exercises.

A typical purchase (the median) is worth €6,717. Of 6 purchases, 5 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 15 December 2025 came the latest disclosure, a share grant in Jaguar Health, Inc. The last insider purchase was made public on 25 July 2019, 2,648 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.